1. Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes. (25th November 2020) Authors: Ray, K.K; Nicholls, S.J; Buhr, K.A; Ginsberg, H.N; Kalantar-Zadeh, K; Johansson, J.O; Kulikowski, E; Toth, P.P; Wong, N; Sweeney, M; Schwartz, G.G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline triglycerides and non-HDL-C and apoB goal attainment in the ORION-10 and ORION-11 trials. (25th November 2020) Authors: Ray, K.K; Kallend, D; Raal, F.J; Stoekenbroek, R; Koenig, W; Leiter, L.A; Landmesser, U; Schwartz, G.G; Wijngaard, P.L.J; Kastelein, J.J.P; Wright, R.S Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Do European patients with peripeheral arterial disease receive optimal lipid lowering therapy and achieve LDL-C goals? Results from the DA VINCI study. (25th November 2020) Authors: Ray, K.K; Feudjo Tepie, M; Catapano, A.L; Giovas, P; Bray, S; Masana, L; Weiss, N; Poulter, N Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study. (25th November 2020) Authors: Ray, K.K; Bruckert, E; Van Hout, B; Feudjo Tepie, M; Bridges, I; Sibartie, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of bempedoic acid on uric acid and gout in 3621 patients with hypercholesterolemia: pooled analyses from phase 3 trials. (25th November 2020) Authors: Ray, K.K; Bakris, G.L; Banach, M; Catapano, A; Duell, P.B; Mancini, G.B.J; Bloedon, L; Feng, A; Gotto Jr, A.M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inter-individual variability in LDL-C reductions with inclisiran – data from ORION-10 and ORION-11. (25th November 2020) Authors: Wright, R.S; Raal, F.J; Kallend, D; Stoekenbroek, R; Koenig, W; Leiter, L.A; Landmesser, U; Schwartz, G.G; Wijngaard, P.L.J; Kastelein, J.J.P; Ray, K.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study. (25th November 2020) Authors: Ballantyne, C.M; Banach, M; Bays, H.E; Catapano, A.L; Laufs, U; Stroes, E.S.G; Bloedon, L; Feng, A; Robinson, P; Ray, K.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11). (25th November 2020) Authors: Wright, R.S; Kallend, D; Raal, F.J; Stoekenbroek, R; Koenig, W; Leiter, L.A; Landmesser, U; Schwartz, G; Wijngaard, P.L.J; Kastelein, J.J.P; Ray, K.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. What is the potential cardiovascular risk reduction associated with achieving LDL-C levels recommended in the ESC/EAS guidelines for very high-risk patients? Data from 18 European countries. (25th November 2020) Authors: Ray, K.K; Bray, S; Catapano, A.L; Poulter, N; Villa, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries. (25th November 2020) Authors: Ray, K.K; Bridges, I; Bruckert, E; Van Hout, B; Sibartie, M; Villa, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗